Funding for this research was provided by:
Michael J. Fox Foundation for Parkinson’s Research (MJFF 16944)
GE Global Research Center, Niskayuna, NY.
Received: 11 September 2020
Accepted: 21 April 2021
First Online: 24 May 2021
: R.M., S.E.J. and J.A. are employees at General Electric. B.L. is now a Medtronic employee; he was not at the time of this work completion. Medtronic had no role in data acquisition, analysis, or interpretation. A.F. serves as a consultant for Medtronic, Abbott, Boston Scientific, Brainlab, Ceregate, and Medtronic, he received research grants, personal fees and non-financial support from Boston Scientific, Brainlab and Medtronic and personal fees from Abbott and Ceregate, all outside the submitted work. S.K.K. reports honorarium and consulting fees from Medtronic. A.M.L. serves as a consultant for Medtronic, Abbott, Boston Scientific, and Functional Neuromodulation. A.B., R.M., S.E.J., J.A. and A.M.L. have intellectual property related to this manuscript. The other authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.